Tanuma Michiya, Sakurai Takayuki, Nakaminami Hidemasa, Tanaka Masayo
Department of Pharmacy, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-Ku, Tokyo, 141-8625, Japan.
Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
J Pharm Health Care Sci. 2025 Mar 28;11(1):24. doi: 10.1186/s40780-025-00429-2.
Stenotrophomonas maltophilia (S. maltophilia) is a Gram-negative pathogen that causes opportunistic infections. Although the mortality rate among patients with nosocomial infections caused by S. maltophilia is high, the risk factors for infection vary among studies. Moreover, S. maltophilia is highly resistant to several classes of antimicrobial agents. To date, few studies on S. maltophilia have been conducted in Japan, and the details remain unclear. Therefore, the objective of this study was to investigate the risk factors associated with S. maltophilia infection and the antimicrobial susceptibility of S. maltophilia isolates identified in our hospital.
In this study, we investigated the risk factors associated with S. maltophilia infection and clinical characteristics isolated from patients at the NTT Medical Center Tokyo (Tokyo, Japan). We retrospectively examined the S. maltophilia isolates and the corresponding patients between March 2022 and August 2023.
Fifty-eight patients with S. maltophilia isolated (median age, 80.5 years; age range, 49-100 years; 70.7% male) were enrolled in this study. Twelve cases (20.7%) were placed in the S. maltophilia infection group and 46 cases were placed in the S. maltophilia colonization group. Central venous (CV) catheterization and higher Sequential Organ Failure Assessment (SOFA) scores were identified as risk factors for S. maltophilia infection. In addition, the 30-day mortality rate was significantly higher, and the survival rate was significantly lower in patients with S. maltophilia infection. The antimicrobial susceptibility rates of S. maltophilia were as follows: 28.6% for ceftazidime, 2.4% for cefozopran, 96.6% for levofloxacin, 100% for minocycline, and 98.3% for trimethoprim-sulfamethoxazole.
In actual clinical practice, S. maltophilia was more frequently isolated from sputum. However, most of the cases were colonization, and cases of infection were rare. Early treatment initiation should be considered for S. maltophilia infection in cases where the pathogen is detected from sterile sites, such as blood cultures and pleural fluid or from sputum in cases with a high SOFA score and CV catheter insertion.
嗜麦芽窄食单胞菌是一种可引起机会性感染的革兰氏阴性病原体。尽管嗜麦芽窄食单胞菌引起的医院感染患者死亡率较高,但不同研究中感染的危险因素各不相同。此外,嗜麦芽窄食单胞菌对几类抗菌药物具有高度耐药性。迄今为止,日本针对嗜麦芽窄食单胞菌的研究较少,具体情况仍不清楚。因此,本研究的目的是调查与嗜麦芽窄食单胞菌感染相关的危险因素以及我院分离出的嗜麦芽窄食单胞菌菌株的抗菌药敏情况。
在本研究中,我们调查了东京NTT医疗中心(日本东京)患者中与嗜麦芽窄食单胞菌感染相关的危险因素及分离出的临床特征。我们回顾性研究了2022年3月至2023年8月期间分离出的嗜麦芽窄食单胞菌菌株及相应患者。
本研究纳入了58例分离出嗜麦芽窄食单胞菌的患者(中位年龄80.5岁;年龄范围49 - 100岁;男性占70.7%)。12例(20.7%)被归入嗜麦芽窄食单胞菌感染组,46例被归入嗜麦芽窄食单胞菌定植组。中心静脉(CV)置管和较高的序贯器官衰竭评估(SOFA)评分被确定为嗜麦芽窄食单胞菌感染的危险因素。此外,嗜麦芽窄食单胞菌感染患者的30天死亡率显著更高,生存率显著更低。嗜麦芽窄食单胞菌的抗菌药敏率如下:头孢他啶为28.6%,头孢唑肟为2.4%,左氧氟沙星为96.6%,米诺环素为100%,复方磺胺甲恶唑为98.3%。
在实际临床实践中,嗜麦芽窄食单胞菌更常从痰液中分离出来。然而,大多数病例为定植,感染病例很少。对于从无菌部位(如血培养和胸腔积液)检测到病原体的嗜麦芽窄食单胞菌感染病例,或SOFA评分高且有CV置管的痰液病例,应考虑尽早开始治疗。